Albemarle (ALB) stock
Materials · Specialty Chemicals
Albemarle (ALB) is a Specialty Chemicals company in the Materials sector, headquartered in Charlotte, North Carolina. As of October 23, 2026, ALB closed at $93.67, a market capitalization of $11.05 billion, the 484th largest company in the S&P 500. Over the last twelve months it generated $5.91 billion in revenue (+31% year over year) and $1.34 billion in free cash flow. The stock trades at 346.9x trailing earnings and 8.7x forward earnings.
- 1-year total return: -2.7% (dividends reinvested)
- 5-year return: -15.5% a year
- 52-week range: $88.01 – $221.00
- Gross margin 24.0%, operating margin 27.7%
- Dividend yield: 1.75%, 31 straight years of increases
- FI Handbook report card: B- across 10 metrics
- 23rd largest of 24 Materials stocks in the S&P 500
ALB price chart
1Y price change: -3.8% (price only; total returns below include dividends)
| Total return | 1M | YTD | 1Y | 3Y | 5Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|
| ALB | -17.4% | -33.2% | -2.7% | -10.3% | -15.5% | +2.7% | +10.0% |
Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 1994.
ALB key statistics
- Market cap
- $11.1B
- #484 in S&P 500
- P/E (TTM)
- 346.9x
- Forward P/E
- 8.7x
- EPS (TTM)
- $0.27
- Revenue (TTM)
- $5.9B
- +31%
- Free cash flow
- $1.3B
- Gross margin
- 24.0%
- Operating margin
- 27.7%
- Return on equity
- 2.6%
- Dividend yield
- 1.75%
- 52-week range
- $88.01 – $221.00
- Beta
- 1.36
- Price / sales
- 1.9x
- EV / EBITDA
- 9.4x
- Debt / equity
- 0.19x
- Employees
- 7,800
ALB report card
B-Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.
- Revenue growth31.1%A
- Gross margin24.0%D
- Operating margin27.7%B
- FCF margin22.7%B
- Return on equity2.6%F
- Net debt / EBITDA0.2xB
- Forward P/E8.7xA
- PEG ratio0.8xA
- Shareholder yield1.8%C
- Share count change / yr2.0%D
Albemarle financials
Revenue went from $2.7B in fiscal 2016 to $5.1B in fiscal 2025, growing 7.5% a year.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.1B | $3.4B | $3.6B | $3.1B | $3.3B | $7.3B | $9.6B | $5.4B | $5.1B |
| Gross profit | $970.3M | $1.1B | $1.2B | $1.3B | $994.9M | $998.0M | $3.1B | $1.2B | $62.5M | $668.7M |
| Operating income | $601.0M | $571.7M | $911.5M | $666.1M | $505.8M | $798.4M | $2.5B | $251.9M | -$1.8B | -$367.1M |
| Net income | $643.7M | $54.9M | $693.6M | $533.2M | $375.8M | $123.7M | $2.7B | $1.6B | -$1.2B | -$510.6M |
| EPS (diluted) | $5.68 | $0.49 | $6.34 | $5.02 | $3.52 | $1.06 | $22.84 | $13.36 | $-11.20 | $-5.76 |
| Free cash flow | $538.9M | -$13.7M | -$153.8M | -$132.4M | -$51.6M | -$609.4M | $646.2M | -$828.0M | -$992.7M | $692.5M |
| Buybacks | $0 | $250.0M | $500.0M | $0 | $0 | — | — | — | — | — |
| Dividends paid | $135.4M | $140.6M | $144.6M | $152.2M | $161.8M | $177.9M | $184.4M | $187.2M | $188.5M | $190.5M |
| Diluted shares | 113.2M | 112.4M | 109.5M | 106.3M | 106.8M | 116.5M | 117.8M | 117.8M | 117.5M | 117.7M |
Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.
What's priced into ALB?
A reverse DCF asks what growth the current price requires. With an enterprise value of $11.4B and $1.3B of trailing free cash flow, Albemarle needs to grow free cash flow about -10.0% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return.
P/E ratio history
Current 5.8x vs. median 18.6x (10th–90th percentile 9.3x–189.0x).
A model, not a forecast or advice. Small changes in assumptions move the answer a lot.
ALB dividend
- Dividend yield
- 1.75%
- Annual dividend
- $1.64
- Years of increases
- 31
- 5-yr dividend growth
- 1.0%
- per year
- Payout ratio
- 600%
- Payments per year
- 4
Regular dividends per share by calendar year; special dividends excluded. Current year omitted until complete.
ALB analyst price targets
21 analysts' average 12-month target is $156.35 (+67% vs. $93.67). Targets range from $83.28 to $211.00. 61% rate it a buy.
ALB earnings
Next report: November 4, 2026. Albemarle has beaten EPS estimates 2 quarters in a row. Last quarter's revenue was $1.7B (+31% year over year).
| Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Aug 5, 2026 | $3.24 | $3.75 | +15.7% |
| May 6, 2026 | $1.31 | $2.95 | +124.6% |
| Feb 11, 2026 | $-0.49 | $-0.53 | -8.6% |
| Nov 5, 2025 | $-0.88 | $-0.19 | +78.3% |
| Jul 30, 2025 | $-0.81 | $0.11 | +113.5% |
| Apr 30, 2025 | $-0.68 | $-0.18 | +73.5% |
| Feb 12, 2025 | $-0.67 | $-1.09 | -63.0% |
| Nov 6, 2024 | $-0.48 | $-1.55 | -221.7% |
Stocks like ALB
| Name | Today | 1Y | Mkt cap | P/E | |
|---|---|---|---|---|---|
 SHW Sherwin-Williams | -2.48% | +3% | $81.8B | 31.1x | Compare |
 ECL Ecolab | -1.29% | +6% | $80.9B | 38.7x | Compare |
 PPG PPG Industries | -2.19% | +10% | $24.6B | 15.9x | Compare |
 IFF International Flavors & Fragran | +0.34% | +46% | $24.0B | 93.2x | Compare |
 LYB LyondellBasell Industries NV | +1.65% | +51% | $21.5B | — | Compare |
 LIN Linde | -0.30% | +15% | $234.6B | 32.8x | Compare |
 NEM Newmont | -4.59% | +24% | $113.1B | 12.6x | Compare |
 FCX Freeport-McMoRan | +0.91% | +60% | $93.6B | 32.1x | Compare |
ALB news
- Should Q3 Earnings Report Require Action From Albemarle (ALB) Investors? · Oct 25, 2026
- Can Albemarle Stock Jump 50%? · Oct 23, 2026
- Albemarle (ALB) Gains As Market Dips: What You Should Know · Oct 23, 2026
- What to Expect From Albemarle's Q3 2026 Earnings Report · Oct 23, 2026
- Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights · Oct 22, 2026
ALB stock FAQ
What is ALB's market cap?
Albemarle's market capitalization is $11.05 billion as of October 23, 2026, ranking 484th in the S&P 500.
What is ALB's P/E ratio?
ALB trades at a trailing price-to-earnings ratio of 346.9x and a forward P/E of 8.7x. Its median P/E over the period we track is 18.6x.
Does ALB pay a dividend?
Yes. Albemarle pays $1.64 per share a year, a 1.75% yield. It has raised its dividend 31 years in a row. Dividends grew 1.0% a year over the last five years.
How much has ALB stock returned?
Including reinvested dividends, ALB returned -2.7% over one year, -15.5% a year over five years, +2.7% a year over ten years through October 23, 2026.
Is ALB stock overvalued?
At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies Albemarle must grow free cash flow about -10% a year for the next decade. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.
What is the ALB price target?
21 analysts cover ALB with an average 12-month price target of $156.35, +67% from the current price. 61% of them rate it a buy.
When does ALB report earnings?
Albemarle is expected to report earnings on November 4, 2026. It has beaten EPS estimates 2 quarters in a row.
How many employees does Albemarle have?
Albemarle has about 7,800 full-time employees, or $757,424 of revenue per employee.
Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology